IBIO vs PEP · rev $100.0K vs P/E 22, rev $43.62B
iBio, Inc. Common Stock (IBIO) versus PepsiCo Inc (PEP) — a side-by-side from cached financials, not a winner call.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
PepsiCo Inc (PEP) is a beverages - non-alcoholic company listed on NASDAQ. It is led by Ramon Laguarta.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
Latest reported PEP revenue for 2026-06-13 was $43.62B. Net income was $5.31B. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
IBIO currently screens at market cap $13.4M. PEP currently screens at market cap $193.55B and trailing P/E 22.2.
Not investment advice. Open the IBIO and PEP stock pages for the full models.
Not investment advice.